is tirzepatide dangerous long term did not impact metabolic adaptation in people with obesity, but increased fat oxidation #SmoothieAddIn Amount:10MG GIPR/GLP-1R dual agonist therapies

is tirzepatide dangerous long term did not impact metabolic adaptation in people with obesity, but increased fat oxidation #SmoothieAddIn Amount:10MG GIPR/GLP-1R dual agonist therapies

GIPR/GLP-1R dual agonist therapies for diabetes and weight loss– Chemistry, Physiology and Clinical application - PMC

“I also studied appetite, or how people experience and attempt to control their appetite, my whole career

#SmoothieAddIn

Amount:10MG

Some patients might prefer using Wegovy because its dosage comes in a prefilled, single-use pen, while Saxenda’s multi-dose pen allows the patient to use one pen for several doses but needs setup